SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Prasanth Surampudi, Ronald S Swerdloff, Christina Wang, An update on male hypogonadism therapy, Expert Opinion on Pharmacotherapy, 2014, 15, 9, 1247

    CrossRef

  2. 2
    Giovanni Corona, Elisa Maseroli, Mario Maggi, Injectable testosterone undecanoate for the treatment of hypogonadism, Expert Opinion on Pharmacotherapy, 2014, 15, 13, 1903

    CrossRef

  3. 3
    Giacomo Tirabassi, Nicola delli Muti, Giovanni Corona, Mario Maggi, Giancarlo Balercia, Androgen Receptor Gene CAG Repeat Polymorphism Regulates the Metabolic Effects of Testosterone Replacement Therapy in Male Postsurgical Hypogonadotropic Hypogonadism, International Journal of Endocrinology, 2013, 2013, 1

    CrossRef

  4. 4
    Sylvie Salenave, Sévérine Trabado, Luigi Maione, Sylvie Brailly-Tabard, Jacques Young, Male acquired hypogonadotropic hypogonadism: Diagnosis and treatment, Annales d'Endocrinologie, 2012, 73, 2, 141

    CrossRef

  5. 5
    Peter Lyngdorf, Testosterone undecanoate: a review, Aging Health, 2012, 8, 4, 341

    CrossRef

  6. 6
    Sigmund Brabrand, Sophie D. Fosså, Milada Cvancarova, Gustav Lehne, Androgen substitution with testosterone undecanoate in survivors of bilateral testicular cancer requires individually-adjusted injection intervals, BJU International, 2011, 107, 7
  7. 7
    F. Saad, A. Aversa, A. M. Isidori, L. Zafalon, M. Zitzmann, L. Gooren, Onset of effects of testosterone treatment and time span until maximum effects are achieved, European Journal of Endocrinology, 2011, 165, 5, 675

    CrossRef

  8. 8
    Du Geon Moon, Min Gu Park, Sung Won Lee, Kwangsung Park, Jong Kwan Park, Sae Woong Kim, Nam Cheol Park, Tai Young Ahn, Jae Seung Paick, Ju Tae Seo, Dae Yul Yang, June Young Lee, Je Jong Kim, The Efficacy and Safety of Testosterone Undecanoate (Nebido®) in Testosterone Deficiency Syndrome in Korean: A Multicenter Prospective Study, The Journal of Sexual Medicine, 2010, 7, 6
  9. 9
    A. Mathur, C. Malkin, B. Saeed, R Muthusamy, T H. Jones, K. Channer, Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men, European Journal of Endocrinology, 2009, 161, 3, 443

    CrossRef

  10. 10
    Emily Pfeil, Adrian S Dobs, Current and future testosterone delivery systems for treatment of the hypogonadal male, Expert Opinion on Drug Delivery, 2008, 5, 4, 471

    CrossRef

  11. 11
    Robert Moisey, Julie Swinburne, Steve Orme, Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM – Nebido®), Clinical Endocrinology, 2008, 69, 4
  12. 12
    Farid Saad, Axel Kamischke, Aksam Yassin, Michael Zitzmann, Markus Schubert, Friedrich Jockenhövel, Hermann M. Behre, Louis Gooren, Eberhard Nieschlag, More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate, Asian Journal of Andrology, 2007, 9, 3
  13. 13
    A Seftel, Testosterone replacement therapy for male hypogonadism: Part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents, International Journal of Impotence Research, 2007, 19, 1, 2

    CrossRef

  14. 14
    Daniel Edelstein, Mala Sivanandy, Sadeka Shahani, Shehzad Basaria, The latest options and future agents for treating male hypogonadism, Expert Opinion on Pharmacotherapy, 2007, 8, 17, 2991

    CrossRef

  15. 15
    Christina Wang, Male Reproductive Dysfunction, 2007,

    CrossRef

  16. 16
    Maria Cristina Meriggiola, Antonietta Costantino, Silvia Cerpolini, Laura DʼEmidio, Francesca Armillotta, Marta Berra, Giuseppe Pelusi, Androgens and male contraception, Current Opinion in Endocrinology and Diabetes, 2006, 13, 3, 278

    CrossRef

  17. 17
    Daniel Edelstein, Adrian Dobs, Shehzad Basaria, Emerging drugs for hypogonadism, Expert Opinion on Emerging Drugs, 2006, 11, 4, 685

    CrossRef

  18. 18
    Markus Schubert, Michael Zitzmann, Aksam Yassin, Intramuscular testosterone undecanoate for the treatment of male hypogonadism–review of recent data, The Journal of Men's Health & Gender, 2006, 3, 4, 356

    CrossRef

  19. 19
    Aksam A Yassin, Doris Huebler, Farid Saad, Long-acting testosterone undecanoate for parenteral testosterone therapy, Therapy, 2006, 3, 6, 709

    CrossRef

  20. 20
    Aksam A Yassin, Doris Huebler, Farid Saad, Long-acting testosterone undecanoate for parenteral testosterone therapy, Therapy, 2006, 3, 6, 709

    CrossRef

  21. 21
    DUNCAN C. GOULD, MARK R. FENELEY, ROGER S. KIRBY, PROSTATE-SPECIFIC ANTIGEN TESTING IN HYPOGONADISM: IMPLICATIONS FOR THE SAFETY OF TESTOSTERONE-REPLACEMENT THERAPY, BJU International, 2006, 98, 1
  22. 22
    Marie-Laure Leichtnam, Hervé Rolland, Patrick Wüthrich, Richard H. Guy, Testosterone Hormone Replacement Therapy: State-of-the-Art and Emerging Technologies, Pharmaceutical Research, 2006, 23, 6, 1117

    CrossRef

  23. 23
    Eberhard Nieschlag, Testosterone treatment comes of age: new options for hypogonadal men, Clinical Endocrinology, 2006, 65, 3
  24. 24
    Lars Söderberg, Henrik Dyhre, Bodil Roth, Sven Björkman, The “inverted cup” — A novel in vitro release technique for drugs in lipid formulations, Journal of Controlled Release, 2006, 113, 1, 80

    CrossRef

  25. 25
    Ammar Qoubaitary, Ronald S Swerdloff, Christina Wang, Advances in male hormone substitution therapy, Expert Opinion on Pharmacotherapy, 2005, 6, 9, 1493

    CrossRef

  26. 26
    Emily Darby, Bradley D Anawalt, Male Hypogonadism, Treatments in Endocrinology, 2005, 4, 5, 293

    CrossRef

  27. 27
    Lindsey Harle, Shehzad Basaria, Adrian S Dobs, Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism, Expert Opinion on Pharmacotherapy, 2005, 6, 10, 1751

    CrossRef

  28. 28
    Joachim Wistuba, C. Marc Luetjens, Axel Kamischke, Yi-Qun Gu, Stefan Schlatt, Manuela Simoni, Eberhard Nieschlag, Pharmacokinetics and pharmacodynamics of injectable testosterone undecanoate in castrated cynomolgus monkeys (Macaca fascicularis) are independent of different oil vehicles, Journal of Medical Primatology, 2005, 34, 4
  29. 29
    Friedrich Jockenhövel, Joel M. Kaufman, Gerald H. Mickisch, Alvaro Morales, Christina Wang, The good, the bad, and the unknown of late onset hypogonadism: the urological perspective, The Journal of Men's Health & Gender, 2005, 2, 3, 292

    CrossRef

  30. 30
    Louis J G Gooren, Mathijs C M Bunck, Androgen Replacement Therapy, Drugs, 2004, 64, 17, 1861

    CrossRef

  31. 31
    Christina Wang, Ronald S Swerdloff, Male hormonal contraception, American Journal of Obstetrics and Gynecology, 2004, 190, 4, S60

    CrossRef

  32. 32
    Axel Kamischke, Eberhard Nieschlag, Progress towards hormonal male contraception, Trends in Pharmacological Sciences, 2004, 25, 1, 49

    CrossRef

  33. 33
    D. Schultheiss, S. Machtens, U. Jonas, Review article Testosterone therapy in the ageing male: what about the prostate?, Andrologia, 2004, 36, 6
  34. 34
    Fabio Lanfranco, Michael Zitzmann, Manuela Simoni, Eberhard Nieschlag, Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy, Clinical Endocrinology, 2004, 60, 4
  35. 35
    John K. Amory, William J. Bremner, Regulation of testicular function in men: implications for male hormonal contraceptive development, The Journal of Steroid Biochemistry and Molecular Biology, 2003, 85, 2-5, 357

    CrossRef

  36. 36
    Brian M Brady, Richard A Anderson, Advances in male contraception, Expert Opinion on Investigational Drugs, 2002, 11, 3, 333

    CrossRef

  37. 37
    A. V. Pechersky, V. I. Mazurov, V. F. Semiglazov, A. I. Karpischenko, V. V. Mikhailichenko, A. V. Udintsev, Androgen administration in middle-aged and ageing men: effects of oral testosterone undecanoate on dihydrotestosterone, oestradiol and prostate volume, International Journal of Andrology, 2002, 25, 2
  38. 38
    M. Zitzmann, E. Nieschlag, Der Altershypogonadismus des Mannes, Reproduktionsmedizin, 2002, 18, 5, 241

    CrossRef

  39. 39
    R.A Anderson, H Zhu, L Cheng, D.T Baird, Investigation of a novel preparation of testosterone decanoate in men: pharmacokinetics and spermatogenic suppression with etonogestrel implants, Contraception, 2002, 66, 5, 357

    CrossRef

  40. 40
    D. Kinniburgh, H. Zhu, L. Cheng, A.T. Kicman, D.T. Baird, R.A. Anderson, Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men, Human Reproduction, 2002, 17, 6, 1490

    CrossRef

  41. 41
    M.C. Meriggiola, A. Costantino, S. Cerpolini, Recent advances in hormonal male contraception, Contraception, 2002, 65, 4, 269

    CrossRef

  42. 42
    Vincent Flynn, Wayne J. G. Hellstrom, Androgen deficiency in the aging male: Pathophysiology, diagnosis, and treatment alternatives, Current Urology Reports, 2001, 2, 6, 473

    CrossRef

  43. 43
    Frances J. Hayes, Androgen replacement in the male: recent studies, Current Opinion in Endocrinology & Diabetes, 2001, 8, 6, 301

    CrossRef

  44. 44
    John K. Amory, William Bremner, Endocrine regulation of testicular function in men: implications for contraceptive development, Molecular and Cellular Endocrinology, 2001, 182, 2, 175

    CrossRef

  45. 45
    Alessandra Gambineri, Carla Pelusi, Valentina Vicennati, Uberto Pagotto, Renato Pasquali, Testosterone in ageing men, Expert Opinion on Investigational Drugs, 2001, 10, 3, 477

    CrossRef

  46. 46
    Nayahmka J. McGriff, Gyorgy Csako, Mahmoud Kabbani, Long Diep, George P. Chrousos, Frank Pucino, Treatment Options for a Patient Experiencing Pruritic Rash Associated with Transdermal Testosterone: A Review of the Literature, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001, 21, 11
  47. 47
    Axel Kamischke, Daniela Plöger, Stefan Venherm, Sigrid Von Eckardstein, Arnold Von Eckardstein, Eberhard Nieschlag, Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasability study for male contraception, Clinical Endocrinology, 2000, 53, 1